126 related articles for article (PubMed ID: 27233426)
1. Multi-center and multi-method evaluation of in vitro activities of ceftaroline against S. aureus.
Koeth LM; Apfalter P; Becker K; Gesu G; Martínez-Martínez L; Lahiri SD; Alm RA; Ambler J; Iaconis J
Diagn Microbiol Infect Dis; 2016 Aug; 85(4):452-8. PubMed ID: 27233426
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
[TBL] [Abstract][Full Text] [Related]
3. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.
Koeth LM; Matuschek E; Kahlmeter G; Alm RA; Ambler JE
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1511-7. PubMed ID: 24744220
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
5. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
Cantón R; Livermore DM; Morosini MI; Díaz-Regañón J; Rossolini GM;
J Antimicrob Chemother; 2017 Feb; 72(2):431-436. PubMed ID: 27798220
[TBL] [Abstract][Full Text] [Related]
6. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
Sader HS; Flamm RK; Farrell DJ; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
[TBL] [Abstract][Full Text] [Related]
7. Activity of ceftaroline and comparator agents tested against Staphylococcus aureus from patients with bloodstream infections in US medical centres (2009-13).
Sader HS; Farrell DJ; Flamm RK; Jones RN
J Antimicrob Chemother; 2015 Jul; 70(7):2053-6. PubMed ID: 25814163
[TBL] [Abstract][Full Text] [Related]
8. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
Urbán E; Stone GG
Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of the Thermo Fisher Scientific (Sensititre™) dry-form broth microdilution MIC product when testing ceftaroline.
Jones RN; Holliday NM; Critchley IA
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):280-2. PubMed ID: 25623933
[TBL] [Abstract][Full Text] [Related]
10. A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.
Khan A; Rivas LM; Spencer M; Martinez R; Lam M; Rojas P; Porte L; Silva F; Braun S; Valdivieso F; Mv Lhauser M; Lafourcade M; Miller WR; García P; Arias CA; Munita JM
J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315958
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.
Karlowsky JA; Biedenbach DJ; Bouchillon SK; Iaconis JP; Reiszner E; Sahm DF
J Antimicrob Chemother; 2016 Jan; 71(1):162-9. PubMed ID: 26503667
[TBL] [Abstract][Full Text] [Related]
12. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
Bengtsson S; Bjelkenbrant C; Kahlmeter G
Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Sader HS; Fritsche TR; Jones RN
Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.
Morrissey I; Leakey A; Northwood JB
Int J Antimicrob Agents; 2012 Sep; 40(3):227-34. PubMed ID: 22796201
[TBL] [Abstract][Full Text] [Related]
15. Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
Farrell DJ; Flamm RK; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):86-8. PubMed ID: 23146404
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
[TBL] [Abstract][Full Text] [Related]
17. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2013 Apr; 41(4):337-42. PubMed ID: 23466338
[TBL] [Abstract][Full Text] [Related]
18. Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
Lahiri SD; Alm RA
J Antimicrob Chemother; 2016 Jan; 71(1):34-40. PubMed ID: 26483514
[TBL] [Abstract][Full Text] [Related]
19. Multicenter evaluation of the Etest and disk diffusion methods for differentiating daptomycin-susceptible from non-daptomycin-susceptible Staphylococcus aureus isolates.
Jevitt LA; Thorne GM; Traczewski MM; Jones RN; McGowan JE; Tenover FC; Brown SD
J Clin Microbiol; 2006 Sep; 44(9):3098-104. PubMed ID: 16954233
[TBL] [Abstract][Full Text] [Related]
20. Ceftaroline activity against bacterial pathogens frequently isolated in U.S. medical centers: results from five years of the AWARE surveillance program.
Sader HS; Flamm RK; Streit JM; Farrell DJ; Jones RN
Antimicrob Agents Chemother; 2015 Apr; 59(4):2458-61. PubMed ID: 25645844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]